AWM Investment Company, Inc. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.

Quarter-by-quarter ownership
AWM Investment Company, Inc. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$2,831,000
+42.0%
20,0000.0%0.28%
+25.1%
Q1 2021$1,994,000
-19.3%
20,0000.0%0.22%
-29.0%
Q4 2020$2,472,000
+26.9%
20,0000.0%0.31%
-1.6%
Q3 2020$1,948,000
-79.2%
20,000
-66.7%
0.32%
-80.6%
Q2 2020$9,361,000
+8.1%
60,0000.0%1.64%
-28.5%
Q1 2020$8,660,000
-43.5%
60,000
-20.0%
2.30%
-23.4%
Q4 2019$15,332,000
+154.6%
75,0000.0%3.00%
+134.4%
Q3 2019$6,022,000
-14.9%
75,0000.0%1.28%
-5.5%
Q2 2019$7,076,000
+10.4%
75,0000.0%1.35%
+7.2%
Q1 2019$6,410,000
+52.4%
75,0000.0%1.26%
+37.8%
Q4 2018$4,207,000
-26.5%
75,000
+7.1%
0.92%
-3.2%
Q3 2018$5,723,000
+133.8%
70,0000.0%0.95%
+131.3%
Q2 2018$2,448,000
+83.6%
70,000
+7.7%
0.41%
+59.1%
Q1 2018$1,333,000
-1.8%
65,000
+35.6%
0.26%
-2.3%
Q4 2017$1,357,000
-72.7%
47,929
-70.0%
0.26%
-69.7%
Q3 2017$4,966,000159,6650.87%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders